Journal
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
Volume 9, Issue 4, Pages 626-634Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756283X16642936
Keywords
abdominal pain; diarrhea; lysosomal storage disease; neuropathy
Categories
Funding
- Genzyme
Ask authors/readers for more resources
Fabry disease is a rare X-linked lysosomal storage disease characterized by the dysfunction of multiple systems, including significant gastrointestinal involvement such as diarrhea, abdominal pain, early satiety and nausea. The gastrointestinal symptoms of Fabry disease are thought to be due to neuropathic and myopathic changes leading to symptoms of dysmotility that are encountered in many other disorders. The gastrointestinal symptoms can often be one of the presenting signs of the disease in childhood, but can be misdiagnosed by gastroenterologists for many years due to their nonspecific presentation. As the chief treatment for Fabry is enzyme-replacement therapy that has been shown to stabilize and possibly reverse disease course, recognition of these symptoms and early diagnosis in an attempt to prevent progression with treatment, is critical.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available